In our approach, the i-MeWAS and TH-DM analyses identify the DM CpGs between the two extreme states (i.e., healthy and cancer), while TN-DM analysis identifies DM CpGs between cancer and NAT—which is often considered as an intermediate state between healthy and cancer44. The gene discussed is BRD2; the disease is cancer.